Women, thrombosis, and cancer.
Anticoagulant
Cancer
Contraception
Hormone therapy
Pregnancy
Venous thromboembolism
Women's health issues
Journal
Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
07
01
2019
revised:
12
02
2019
accepted:
15
02
2019
entrez:
4
9
2019
pubmed:
4
9
2019
medline:
4
3
2020
Statut:
ppublish
Résumé
Venous thromboembolism (VTE) is a major common complication in cancer patients. Risk-adapted thromboprophylaxis and antithrombotic therapy for patients diagnosed with VTE can reduce the recurrence of VTE events. Thrombotic risk varies according to cancer type, stage, and comorbidities. The current review analyzes most recent data and provides clinical guidance for the management of women with cancer-associated thrombosis.
Identifiants
pubmed: 31477228
pii: S0049-3848(19)30367-6
doi: 10.1016/S0049-3848(19)30367-6
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S47-S53Informations de copyright
© 2019 Elsevier Ltd. All rights reserved.